Antigen Bound Articles & Analysis

1 news found

Obsidian Therapeutics & MD Anderson announce strategic collaboration to accelerate advancement of novel engineered tumor infiltrating lymphocyte therapy (cytoTIL™) for solid tumors

The collaboration is focused on developing TIL armored with regulated membrane-bound IL15 (referred to as cytoTIL™) with the potential to enhance anti-tumor efficacy and reduce tumor burden in patients suffering from different types of solid tumors. ...

Nov. 18, 2020

ByObsidian Therapeutics, Inc.

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you